Goals of asthma management: A step-care approach

Chest

Volumn 109, Issue 4, 1996, Pages 1056-1065

  Bone, Roger C ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

airway hyperresponsiveness; bronchodilator; circadian rhythm; cytokines; inflammatory response; mediators

Indexed keywords

ADRENALIN; ANTIASTHMATIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BITOLTEROL; BRONCHODILATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FORMOTEROL; ISOETARINE; ISOPRENALINE; NEDOCROMIL; ORCIPRENALINE; PIRBUTEROL; SALBUTAMOL; TERBUTALINE;

ASTHMA; CORTICOSTEROID THERAPY; DISEASE SEVERITY; HUMAN; PATHOPHYSIOLOGY; PATIENT CARE; PATIENT EDUCATION; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING;

EID: 0029913721     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.109.4.1056     Document Type: Article

References (60)

1. Reed CE. New therapeutic approaches in asthma. J Allergy Clin Immunol 1986; 77:537-43
2. Bone RC. A step care strategy for asthma management. J Respir Dis 1988; 9:104-17
3. Bone RC. Step care for asthma. JAMA 1988; 260:543
4. National Heart, Lung, and Blood Institute. National asthma education program: expert panel on the management of asthma: guidelines for the diagnosis and management of asthma. Dept of Health and Human Services publication (NIH) 1991-3042
5. British Thoracic Society. Guidelines on the management of asthma. Thorax 1993; 48:S1-24
6. Pauwels R. The international consensus report on the diagnosis and management of asthma. Eur Respir Rev 1993; 3:483-89
7. Holgate ST. The role of mediators and inflammation in asthma. J Respir Dis 1987; 8:20-37
8. Burrows B, Bloom JW, Traver GA, et al. The course and prognosis of different forms of chronic airways obstruction in a sample of the general population. N Engl J Med 1987; 317:1309-12
9. Hetzel MR, Clark TJH. Comparison of normal and asthmatic circadian rhythms in peak inspiratory flow rate. Thorax 1980; 152:511-17
10. Martin RJ, Cicutto LC, Smith HR, et al. Airway inflammation in nocturnal asthma. Am Rev Respir Dis 1991; 143:351-57
11. Seaton A, Godden DJ, Brown K. Increases in asthma: a more toxic environment or a more susceptible population? Thorax 1994; 49:171-74
12. Call RS, Smith TF, Morris E, et al. Risk factors for asthma in inner city children. J Pediatr 1992; 121:862-66
13. Peat JK, Tovey EJ, Mellis CM, et al. Importance of house dust-mite and Alternaria allergens in childhood asthma: an epidemiological study of Australia. Clin Exp Allergy 1993; 23:812-20
14. Magnussen H, Jorres R. Effect of air pollution on the prevalence of asthma and allergy: lessons from the German reunification. Thorax 1993; 48:879-81
15. Forastiere F, Corbo GM, Pistelli R, et al. Bronchial responsiveness in children living in areas with different air pollution levels. Arch Environ Health 1994; 49:111-18
16. Eliopoulos C, Klein J, Phan MK, et al. Hair concentrations of nicotine and cotinine in women and their newborn infants. JAMA 1994; 271:621-23
17. Cook DG, Whincup PH, Jarvis MJ, et al. Passive exposure to tobacco smoke in children aged 5-7 years: individual, family and community factors. BMJ 1994; 308:384-89
18. Peat JK, Woolcock AJ. Trackling asthma: new approaches to old problems: why not prevent asthma [editorial]? Med J Aust 1994; 160:604-06
19. Tovev E. House dust control measures: are they worthwhile? Mod Med Aust 1993; 8:118-27
20. Warner JA. Creating optimal home conditions for the dust-mite. Clin Exp Allergy 1994; 24:207-09
21. Bousquet J, Francois MB. Immunotherapy in asthma: is it effective? J Allergy Clin Immunol 1994; 94:1-11
22. Mosbech H, Osterballe O. Does the effect of immunotherapy last after termination of treatment? Allergy 1988; 43:523-29
23. Nelson HS, Oppenheimer J, Vatsia GA, et al. A double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized cat extract. J Allergy Clin Immunol 1993; 92:229-36
24. Oppenheimer J, Areson JG, Nelson HS. Safety efficacy of oral inmmnotherapy with standardized cat extract. J Allergy Clin Immunol 1994; 93:61-7
25. Welsh PW, Stricker WE, Chu-pin C, et al. Efficacy of beclomethasone nasal solutions, flunisolide, and cromolyn in relieving symptoms of nasal allergy. Mayo Clin Proc 1987; 62:125-34
26. Watson WT, Becker AB, Simons FER. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness. J Allergy Clin Immunol 1993; 91:97-101
27. Snadden D, Brown JB. The experience of asthma. Soc Sci Med 1992; 34:1351-61
28. Lehrer PM, Isenberg S, Hochron SM. Asthma and emotion: a review. J Asthma 1993; 30:5-21
29. Davis D. Asthma and the psyche [editorial]. Thorax 1993; 48:511
30. Shavitt RG, Gentil V, Mandetta R. Association of panic/agoraphobia and asthma: contributing factors and clinical implications. Gen Hosp Psychiatry 1992; 14:420-23
31. Hodgson SV, McPherson A, Friedman M. The effect of betamethasone valerate aerosol on exercise-induced asthma in children. Postgrad Med J 1974; 50:S69-72
32. 2-agonist, terbutaline on airway inflammation in newly diagnosed asthma: a randomized, double blind, parallel-group controlled trial. J Allergy Clin Immunol 1992; 90:32-42
33. Robinson D, Hamid Q, Ying S, et al. Prednisolone treatment in asthma is associated with modulation of the bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-gamma cytokine gene expression. Am Rev Respir Dis 1993; 148:401-06
34. Henriksen JM. Effect of inhalation of corticosteroids on exercise-induced asthma: randomized double blind crossover study of budesonide in asthmatic children. BMJ 1985; 291:248-49
35. Evans PM, O'Connor BJ, Fuller RW, et al. Effect of inhaled corticosteroids on peripheral blood eosinophil counts and density profiles in asthma. J Allergy Clin Immunol 1993; 91:643-50
36. Rebuck AS, Chapman KR, Abbound R, et al. Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room. Am J Med 1987; 82:59-64
37. Morrison JFJ, Pearson SB, Dean HG. Parasympathetic nervous system in nocturnal asthma. BMJ 1988; 296:1427-29
38. Milgrom H, Bender. Current issues in the use of theophylline. Am Rev Respir Dis 1993; 147:533-39
39. Dompeling E, van Schayck CP, van Grunsven PM, et al. Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. Ann Intern Med 1994; 118:770-78
40. Pederson S, Frost L, Arnfred T. Errors in inhalation technique and efficacy in inhaler use in asthmatic children. Allergy 1986; 41:118-24
41. Schecker MH, Wilson AF, Mukai DS, et al. A device for overcoming discoordination with metered-dose inhalers. J Allergy Clin Immunol 1993; 92:783-89
42. Kumana CR, So SY, Lauder IJ, et al. An audit of antiasthmatic drug inhalation technique and understanding. J Asthma 1993; 30:263-69
43. 2-adrenergic receptors display subtype-selective coupling to Gs. Mol Pharmacol 1992; 41:889-93
44. 2-Adrenergic bronchodilators. Drug Ther 1995; 333:499-506
45. Bone RC. A word of caution regarding a new long-acting bronchodilator. JAMA 1994; 271:1448
46. Beaslev R, Cushley M, Holgate ST. A self-management plan in the treatment of adult asthma. Thorax 1989; 44:200-04
47. Bone RC. Another word of caution regarding a new long-acting bronchodilator. JAMA 1995; 273:967-68
48. Douglas NJ. Nocturnal asthma. Thorax 1993; 48:100-02
49. Kemp JP, Bierman CW, Cocchetto DM. Dose response study of inhaled salmeterol in asthmatic patients with 24-hour spirometry and holter monitoring. Ann Allergy 1993; 70:316-22
50. Brambilla C, Chastang C, Georges D, et al. Salmeterol compared with slow-release terbutaline in nocturnal asthma: a multicenter, randomized, doubleblind, double dummy, sequential clinical trial: French multicenter study group. Allergy 1994; 49:421-26
51. Ramage L, Lipworth BJ, Ingram CG, et al. Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol. Respir Med 1994; 88:363-68
52. Interiano B, Guntupalli KK. Metered-dose inhalers: do health care providers know what to teach? Arch Intern Med 1993; 153:81-5
53. Wilson SR, Scamagas P, German DF, et al. A controlled trial of two forms of self-management education for adults with asthma. Am J Med 1993; 94:564-76
54. 4 excretion. Am Rev Respir Dis 1993; 147:1472-76
55. McMillan R, Walker E. Designing therapeutically effective 5-lipoxygenase inhibitors. Trends Pharmacol Sci 1992; 13:323-30
56. Levine SJ. Bronchial epithelial cell-cytokine interactions in airway inflammation. In: Shelhamer JH, moderator. Airway inflammation. Ann Intern Med 1995; 123:288-304
57. Bone RC. Asthma: new treatments will improve disease management. Clin Pulm Med 1995; 2:1-9
58. Hui K, Taylor G, et al. Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients. Thorax 1991; 46:184-89
59. Israel E, Rubin P, Kemp J, et al. The effect of inhibition of 5-lipoxygenase by zileuton in mild to moderate asthma. Ann Intern Med 1993; 119:1059-66
60. Ford-Hutchinson A. Leukotriene antagonists and inhibitors as modulators of IgE-mediated reactions. Springer Semin Immunopathol 1993; 15:37-50